Search

Laurie A. Scheiner

Examiner (ID: 12886)

Most Active Art Unit
1648
Art Unit(s)
1812, 1802, 1648, 1813, 1807, 1641
Total Applications
650
Issued Applications
403
Pending Applications
88
Abandoned Applications
159

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1080225 [patent_doc_number] => 06835383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Protein kinase deficient, immunologically active CMVpp65 mutants' [patent_app_type] => B2 [patent_app_number] => 09/815330 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8720 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835383.pdf [firstpage_image] =>[orig_patent_app_number] => 09815330 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/815330
Protein kinase deficient, immunologically active CMVpp65 mutants Mar 22, 2001 Issued
Array ( [id] => 6548787 [patent_doc_number] => 20020137918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Immunoglobulin binding protein' [patent_app_type] => new [patent_app_number] => 09/808212 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10734 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137918.pdf [firstpage_image] =>[orig_patent_app_number] => 09808212 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/808212
Immunoglobulin binding protein Mar 12, 2001 Issued
Array ( [id] => 1469530 [patent_doc_number] => 06406870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-18 [patent_title] => 'Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes' [patent_app_type] => B2 [patent_app_number] => 09/798267 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 5 [patent_no_of_words] => 26979 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406870.pdf [firstpage_image] =>[orig_patent_app_number] => 09798267 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/798267
Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes Mar 1, 2001 Issued
Array ( [id] => 1391463 [patent_doc_number] => 06544928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'VIRUS CAPABLE OF SPECIFICALLY INFECTING, GROWING WITHIN, AND LYSING RED TIDE PLANKTON; A METHOD AND AN AGENT FOR PREVENTING RED TIDE USING THE VIRUS; A METHOD FOR ISOLATING THE VIRUS; AND A METHOD FOR SUBCULTURING THE VIRUS' [patent_app_type] => B2 [patent_app_number] => 09/789611 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5159 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544928.pdf [firstpage_image] =>[orig_patent_app_number] => 09789611 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/789611
VIRUS CAPABLE OF SPECIFICALLY INFECTING, GROWING WITHIN, AND LYSING RED TIDE PLANKTON; A METHOD AND AN AGENT FOR PREVENTING RED TIDE USING THE VIRUS; A METHOD FOR ISOLATING THE VIRUS; AND A METHOD FOR SUBCULTURING THE VIRUS Feb 21, 2001 Issued
Array ( [id] => 6618699 [patent_doc_number] => 20020086022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Neutralizing antibody and immunomodulatory enhancing compositions' [patent_app_type] => new [patent_app_number] => 09/780773 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10691 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086022.pdf [firstpage_image] =>[orig_patent_app_number] => 09780773 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/780773
Neutralizing antibody and immunomodulatory enhancing compositions Feb 8, 2001 Abandoned
Array ( [id] => 5800849 [patent_doc_number] => 20020009447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Prophylactic and therapeutic monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 09/781124 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5921 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009447.pdf [firstpage_image] =>[orig_patent_app_number] => 09781124 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/781124
Prophylactic and therapeutic monoclonal antibodies Feb 8, 2001 Issued
Array ( [id] => 935228 [patent_doc_number] => 06974577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-13 [patent_title] => 'Inactivated bovine scours vaccines, processes and method of preventing bovine scours' [patent_app_type] => utility [patent_app_number] => 09/776787 [patent_app_country] => US [patent_app_date] => 2001-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7318 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974577.pdf [firstpage_image] =>[orig_patent_app_number] => 09776787 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/776787
Inactivated bovine scours vaccines, processes and method of preventing bovine scours Feb 3, 2001 Issued
Array ( [id] => 6242196 [patent_doc_number] => 20020045219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Production of human monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 09/759984 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18783 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045219.pdf [firstpage_image] =>[orig_patent_app_number] => 09759984 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/759984
Production of human monoclonal antibodies Jan 11, 2001 Abandoned
Array ( [id] => 1129288 [patent_doc_number] => 06787140 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => B1 [patent_app_number] => 09/724489 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 26489 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787140.pdf [firstpage_image] =>[orig_patent_app_number] => 09724489 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724489
Prevention and treatment of amyloidogenic disease Nov 27, 2000 Issued
Array ( [id] => 1129279 [patent_doc_number] => 06787139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => B1 [patent_app_number] => 09/724102 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 26478 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787139.pdf [firstpage_image] =>[orig_patent_app_number] => 09724102 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724102
Prevention and treatment of amyloidogenic disease Nov 27, 2000 Issued
Array ( [id] => 1129249 [patent_doc_number] => 06787138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => B1 [patent_app_number] => 09/723927 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 26481 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787138.pdf [firstpage_image] =>[orig_patent_app_number] => 09723927 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/723927
Prevention and treatment of amyloidogenic disease Nov 27, 2000 Issued
Array ( [id] => 1129347 [patent_doc_number] => 06787143 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => B1 [patent_app_number] => 09/724477 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 26452 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787143.pdf [firstpage_image] =>[orig_patent_app_number] => 09724477 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724477
Prevention and treatment of amyloidogenic disease Nov 27, 2000 Issued
Array ( [id] => 4377141 [patent_doc_number] => 06294173 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein' [patent_app_type] => 1 [patent_app_number] => 9/724404 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21515 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294173.pdf [firstpage_image] =>[orig_patent_app_number] => 724404 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724404
Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein Nov 27, 2000 Issued
Array ( [id] => 1129350 [patent_doc_number] => 06787144 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => B1 [patent_app_number] => 09/723762 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 26403 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787144.pdf [firstpage_image] =>[orig_patent_app_number] => 09723762 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/723762
Prevention and treatment of amyloidogenic disease Nov 27, 2000 Issued
Array ( [id] => 1383933 [patent_doc_number] => 06544518 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Vaccines' [patent_app_type] => B1 [patent_app_number] => 09/690921 [patent_app_country] => US [patent_app_date] => 2000-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 15130 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544518.pdf [firstpage_image] =>[orig_patent_app_number] => 09690921 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/690921
Vaccines Oct 17, 2000 Issued
Array ( [id] => 1005086 [patent_doc_number] => 06905677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-14 [patent_title] => 'Combined hepatitis B treatment' [patent_app_type] => utility [patent_app_number] => 09/689637 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2015 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/905/06905677.pdf [firstpage_image] =>[orig_patent_app_number] => 09689637 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/689637
Combined hepatitis B treatment Oct 12, 2000 Issued
Array ( [id] => 4348854 [patent_doc_number] => 06291197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Binding moieties for human parvovirus B19' [patent_app_type] => 1 [patent_app_number] => 9/669271 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10339 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291197.pdf [firstpage_image] =>[orig_patent_app_number] => 669271 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/669271
Binding moieties for human parvovirus B19 Sep 25, 2000 Issued
09/463840 AGENT FOR EXPRESSING AND DETECTING A FUSION POLYPEPTIDE WITH AN HPOL-EPITOPE AND A POLYPEPTIDE Jul 16, 2000 Abandoned
09/579933 Traf inhibitors May 25, 2000 Abandoned
Array ( [id] => 1457745 [patent_doc_number] => 06391304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications' [patent_app_type] => B1 [patent_app_number] => 09/529377 [patent_app_country] => US [patent_app_date] => 2000-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7508 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391304.pdf [firstpage_image] =>[orig_patent_app_number] => 09529377 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/529377
Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications May 18, 2000 Issued
Menu